Dupixent 300 mg/2 ml
Dupixent 300 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 66649. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 April 2019 and the authorisation is valid without a time limit. ATC code D11AH05 places the medicine in the group Other dermatological preparations.
| Authorisation number | 66649 |
|---|---|
| Name | Dupixent 300 mg/2 ml |
| Full name | Dupixent 300 mg/2 ml, solution injectable en seringue préremplie avec système de sécurité |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | D11AH05 |
| First authorisation | 05 April 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dupixent 300 mg/2 ml, solution injectable en seringue préremplie avec système de sécurité | B | 05 April 2019 |
| 2 | Dupixent 200 mg/1.14 ml, solution injectable en seringue préremplie avec système de sécurité | B | 19 November 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | Fertigspritze(n) | D11AH05 | 07.15.0. | B |
| 2 | 2 | Fertigspritze(n) | D11AH05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dupixent 300 mg/2 ml authorised in Switzerland?
Yes. Dupixent 300 mg/2 ml is authorised by Swissmedic under authorisation number 66649, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dupixent 300 mg/2 ml have?
Dupixent 300 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dupixent 300 mg/2 ml?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.